tirzepatide gip analog - Dual GLP-1R / GIPR Ligand - Sterile Eli Lilly's GIP/GLP-1 Dual Agonist

& Roe, M

"The triple-agonist design of Retatrutide offers an unprecedented mechanism of action, targeting multiple synergetic metabolic pathways to optimize energetic homeostasis in laboratory models." Preclinical in-vitro models indicate that GIP and GLP-1 receptor activations synergistically stimulate glucose-dependent insulin secretion, while glucagon receptor activation increases cellular energy expenditure and fatty acid oxidation

Fast Australia-wide dispatch

I always love hearing from you

Selective MC1R melanocortin (afamelanotide) research peptide

Sign Up for VCU Health Community Memorial Hospital's E-Newsletter